Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?

Diabetologia

Volumn 53, Issue 5, 2010, Pages 966-970

  Rensing, K L ^a   Houttuijn Bloemendaal, F M ^a   Weijers, E M ^b   Richel, D J ^a   Buller H R ^a   Koolwijk, P ^b   Van Der Loos, C M ^a   Twickler, Th B ^a   Von Der Thusen J H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Angiogenesis; Insulin; Tumour progression; Type 2 diabetes

Indexed keywords

HUMAN INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; INSULIN RECEPTOR;

ADENOCARCINOMA; ARTICLE; BREAST ADENOCARCINOMA; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; INSULIN TREATMENT; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CELLS, CULTURED; COLONIC NEOPLASMS; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; RECEPTOR, INSULIN;

EID: 77952090262     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1687-y     Document Type: Article

References (11)

1. LG Hemkens U Grouven R Bender, et al. 2009 Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Diabetologia 52 1732 1744 10.1007/s00125-009-1418-4 1:CAS:528: DC%2BD1MXpsFyrsL0%3D 19565214
2. JM Jonasson R Ljung M Talback B Haglund S Gudbjornsdottir G Steineck 2009 Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden Diabetologia 52 1745 1754 10.1007/s00125-009-1444-2 1:STN:280:DC%2BD1MrktlygtQ%3D%3D 19588120
3. HM Colhoun SDRN Epidemiology Group 2009 Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetologia 52 1755 1765 10.1007/s00125-009-1453-1 1:STN:280:DC%2BD1Mrktl2kuw%3D%3D 19603149 Erratum 32: 2470
4. CJ Currie CD Poole EA Gale 2009 The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 1766 1777 10.1007/s00125-009-1440-6 1:CAS:528:DC%2BD1MXpsFyrsLo%3D 19572116
5. U Smith EA Gale 2009 Does diabetes therapy influence the risk of cancer? Diabetologia 52 1699 1708 10.1007/s00125-009-1441-5 1:STN:280: DC%2BD1Mrktl2mtQ%3D%3D 19597799
6. KL Rensing F Houttuijn Bloemendaal EM Weijers, et al. 2009 Potential role for insulin in sprouting of neovessels within atherosclerotic plaques; New pathways of microvascular complications in macrovascular disease of diabetes Atherosclerosis Supplement 10 1090 10.1016/S1567-5688(09)71064-5 Abstract
7. Y Liu M Petreaca M Martins-Green 2008 Cell and molecular mechanisms of insulin-induced angiogenesis J Cell Mol Med 12 1 13
8. CM Van der Loos P Teeling 2008 A generally applicable sequential alkaline phosphatase immunohistochemical double staining J Histotechnol 31 119 127
9. CM Van der Loos 2008 Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging J Histochem Cytochem 56 313 328 10.1369/jhc.2007.950170 18158282 (Pubitemid 351429800)
10. P Koolwijk MG van Erck WJ de Vree, et al. 1996 Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity J Cell Biol 132 1177 1188 10.1083/jcb.132.6.1177 1:CAS:528:DyaK28XhvVSlsr0%3D 8601593 (Pubitemid 26105503)
11. P Kurtzhals L Schaffer A Sorensen, et al. 2000 Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use Diabetes 49 999 1005 10.2337/diabetes.49.6.999 1:CAS:528: DC%2BD3cXjvFylu7w%3D 10866053 (Pubitemid 30349423)